📰 Alkermes News
Page 49 - Alkermes News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alkermes. Real-time updates on events, politics, business and more.
November 17, 2022
Here are companies hiring in the healthcare space around Ireland, with jobs in pharma manufacturing, R&D, medical devices and much more.
November 16, 2022
Annual pediatric bariatric procedure rates increased from 2010 to 2017, but utilization is still low.
November 14, 2022
/PRNewswire/ -- DelveInsights PD-1 and PD-L1 Inhibitors Competitive Landscape – 2022 report provides comprehensive global coverage of available, marketed,...
November 14, 2022
PD-1 and PD-L1 inhibitors clinical trial pipeline constitutes 180+ key companies continuously working towards developing 200+ PD-1 and PD-L1 inhibitors drugs, analyzes DelveInsight LAS
November 8, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Stifel 2022 Healthcare Conference on...
November 2, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2022 and updated certain financial expectations for...
November 2, 2022
WASHINGTON (dpa-AFX) - Below are the earnings highlights for Alkermes plc (ALKS):Earnings: -$63.97 million in Q3 vs. -$28.99 million in the same period last year. EPS: -$0.39 in Q3 vs. -$0.18
November 2, 2022
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced approval by its Board of Directors (the Board) to explore separating its commercial-stage...
November 2, 2022
WASHINGTON (dpa-AFX) - (Adds Outlook; Oncology Business Review)Alkermes plc (ALKS) raised its full-year adjusted earnings outlook to $0.15 - $0.33 from $0.09 - $0.27 guided earlier. Analysts expect